Stay updated on Avapritinib in Advanced Mastocytosis Clinical Trial
Sign up to get notified when there's something new on the Avapritinib in Advanced Mastocytosis Clinical Trial page.

Latest updates to the Avapritinib in Advanced Mastocytosis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding avapritinib (BLU-285) and its clinical trial criteria, while adding a new revision number.SummaryDifference20%
- Check16 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check24 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check60 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check74 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check81 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Avapritinib in Advanced Mastocytosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib in Advanced Mastocytosis Clinical Trial page.